| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |